Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 136

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 3
Chunk 136
---
 as amended at our annual general
meeting of shareholders held in August 2023, our directors (other than external directors, if any) are divided into three classes with
staggered three-year terms. Each class of directors consists, as nearly as possible, of one-third of the total number of directors
constituting the entire board of directors. At each annual general meeting of our shareholders beginning in 2024, the election or
re-election of directors following the expiration of the term of office of the directors of that class of directors will be for a term
of office that expires on the third annual general meeting following such election or re-election. Each director (other than external
directors, if any) holds office until the third annual general meeting of our shareholders and until his or her successor is duly appointed,
unless the tenure of such director expires earlier pursuant to the Companies Law, or unless removed from office as described below.

Our directors are divided among three classes as follows:

  the Class I directors, consisting of Dr. Avraham Molcho, Mr. Rami Dar and Gal Cohen, will hold office until our annual general meeting  

  the Class II directors, consisting of Dr. B. J. Bormann and Dr. Raphael Hofstein, will hold office until our annual general meeting  

  the Class III directors, consisting of Dr. Sandra Panem, Dr. Aharon Schwartz and Dr. Shaoyu Yan, will hold office until our annual  

In accordance with the exemption available to foreign private issuers
under applicable Nasdaq Rules, we do not follow the requirements of the Nasdaq Rules with regard to the process of nominating directors,
and instead follow Israeli law and practice, in accordance with which our board of directors is authorized to recommend to our shareholders
director nominees for election, and, in some circumstances, our shareholders may nominate candidates for election as directors by the
shareholders’ general meeting.

In addition, our board of directors may appoint directors (other
than external directors) to fill vacancies on our board of directors, including if the number of directors is below the maximum number
of directors who may serve as provided in our Articles of Association, for a term of office equal to the remaining period of the term
of office of the director(s) whose office(s) has been vacated, or in case of a vacancy due to the number of directors serving being less
than the maximum number stated in our Articles of Association, until the next annual general meeting of our shareholders for the class